Katharina Skoll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katharina Skoll has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Franz Gabor
Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna, Austria
2 shared publications - Maria Anzengruber
Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria
2 shared publications - Michael Wirth
Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna, Austria
2 shared publications - Ammar Tahir
Department of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Vienna, Austria
1 shared publication - Fatlinda Kurtaj
Division of Pharmaceutical Technology and Biopharmaceutics, Faculty of Life Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria
1 shared publication Franz Gabor
1 shared publication
Latest Publications
- Open Access
- 4 May 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1403
A Versatile Brij-Linker for One-Step Preparation of Targeted Nanoparticles
Background: Most frequently the functionalization of nanoparticles is hampered by time-consuming, sometimes harsh conjugation and purification procedures causing premature drug release and/or degradation. A strategy to circumvent multi-step protocols is to synthesize building blocks with different functionalities and to use mixtures thereof for nanoparticle preparation in one step. Methods: BrijS20 was converted into an amine derivative via a carbamate linkage. The Brij-amine readily reacts with pre-activated carboxyl-containing ligands such as folic acid. The structures of the building blocks were confirmed by different spectroscopic methods and their utility was assessed by one-step preparation and characterization of nanoparticles applying PLGA as a matrix polymer. Results: Nanoparticles were about 200 nm in diameter independent of the composition. Experiments with human folate expressing single cells and monolayer revealed that the nanoparticle building block Brij mediates a “stealth” effect and the Brij-amine-folate a “targeting” effect. As compared to plain nanoparticles, the stealth effect decreased the cell interaction by 13%, but the targeting effect increased the cell interaction by 45% in the monolayer. Moreover, the targeting ligand density and thus the cell association of the nanoparticles is easily fine-tuned by selection of the initial ratio of the building blocks. Conclusions: This strategy might be a first step towards the one-step preparation of nanoparticles with tailored functionalities. Relying on a non-ionic surfactant is a versatile approach as it might be extended to other hydrophobic matrix polymers and promising targeting ligands from the biotech pipeline.
- 4 May 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (5) , 1403
Open AccessA Versatile Brij-Linker for One-Step Preparation of Targeted Nanoparticles
Background: Most frequently the functionalization of nanoparticles is hampered by time-consuming, sometimes harsh conjugation and purification procedures causing premature drug release and/or degradation. A strategy to circumvent multi-step protocols is to synthesize building blocks with different functionalities and to use mixtures thereof for nanoparticle preparation in one step. Methods: BrijS20 was converted into an amine derivative via a carbamate linkage. The Brij-amine readily reacts with pre-activated carboxyl-containing ligands such as folic acid. The structures of the building blocks were confirmed by different spectroscopic methods and their utility was assessed by one-step preparation and characterization of nanoparticles applying PLGA as a matrix polymer. Results: Nanoparticles were about 200 nm in diameter independent of the composition. Experiments with human folate expressing single cells and monolayer revealed that the nanoparticle building block Brij mediates a “stealth” effect and the Brij-amine-folate a “targeting” effect. As compared to plain nanoparticles, the stealth effect decreased the cell interaction by 13%, but the targeting effect increased the cell interaction by 45% in the monolayer. Moreover, the targeting ligand density and thus the cell association of the nanoparticles is easily fine-tuned by selection of the initial ratio of the building blocks. Conclusions: This strategy might be a first step towards the one-step preparation of nanoparticles with tailored functionalities. Relying on a non-ionic surfactant is a versatile approach as it might be extended to other hydrophobic matrix polymers and promising targeting ligands from the biotech pipeline.
- Open Access
- 13 November 2022
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 180
LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy
- 13 November 2022
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 180
Open AccessLogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy
- Open Access
- 1 August 2021
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 76, 105617
Characterization of sonochemically prepared human serum albumin nanocapsules using different plant oils as core component for targeted drug delivery
- 1 August 2021
- Published by Elsevier in Ultrasonics Sonochemistry
- Vol. 76, 105617
Open AccessCharacterization of sonochemically prepared human serum albumin nanocapsules using different plant oils as core component for targeted drug delivery